Free Trial

Best Biotechnology Stocks

Biotech stocks open the door to investing in innovation that’s shaping the future of healthcare. From pioneering drug developers to specialized firms in genetic engineering and diagnostics, this sector offers exposure to breakthroughs with the potential for transformative impact—and strong returns. These stocks are known for their potential for high growth but also come with significant volatility due to the complex nature of biotechnological development and regulatory environments.

The list below highlights some of the most widely followed biotech stocks in today’s market. It features a range of companies—from established leaders with approved therapies to up-and-coming firms advancing promising clinical pipelines. View each stock's current price, PE ratio, volume, and recent indicators of potential movement.

MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceP/E RatioMarket CapVolumeAverage VolumeIndicator(s)
AbbVie Inc. stock logo
ABBV
AbbVie
$190.53
+2.2%
81.08$336.55 billion6.18 million6.32 millionTrending News
Analyst Revision
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$416.42
-0.4%
24.42$157.19 billion2.76 million2.01 millionPositive News
Upcoming Earnings
Dividend Announcement
Danaher Corporation stock logo
DHR
Danaher
$193.40
+0.3%
37.55$138.41 billion2.66 million3.52 millionPositive News
Upcoming Earnings
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
$469.55
+1.2%
N/A$120.58 billion777,2111.42 millionTrending News
Analyst Forecast
Analyst Revision
GSK PLC Sponsored ADR stock logo
GSK
GSK
$38.26
+1.2%
19.72$78.34 billion6.28 million5.02 millionTrending News
Cencora, Inc. stock logo
COR
Cencora
$297.83
+1.1%
34.55$57.73 billion1.31 million1.51 millionPositive News
Analyst Forecast
Takeda Pharmaceutical Co. stock logo
TAK
Takeda Pharmaceutical
$14.72
-0.2%
66.89$46.82 billion3.46 million2.02 millionPositive News
Veeva Systems Inc. stock logo
VEEV
Veeva Systems
$282.35
+1.1%
59.82$46.14 billion648,5881.17 millionPositive News
Analyst Forecast
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$322.81
+3.8%
N/A$42.09 billion1.23 million856,651Positive News
Analyst Forecast
Cognizant Technology Solutions Corporation stock logo
CTSH
Cognizant Technology Solutions
$74.83
+0.7%
15.75$36.89 billion2.90 million3.53 millionPositive News
argenex SE stock logo
ARGX
argenex
$577.92
+3.9%
35.65$35.37 billion460,156334,084Positive News
Analyst Revision
IQVIA Holdings Inc. stock logo
IQV
IQVIA
$158.74
+0.7%
21.63$27.28 billion1.48 million1.66 millionUpcoming Earnings
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
$112.49
+1.7%
N/A$27.04 billion786,499978,379Analyst Forecast
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
$35.60
-2.5%
19.24$20.02 billion3.75 million3.71 millionPositive News
International Flavors & Fragrances Inc. stock logo
IFF
International Flavors & Fragrances
$74.28
+0.9%
N/A$19.00 billion1.07 million1.54 million
Illumina, Inc. stock logo
ILMN
Illumina
$96.95
-0.2%
N/A$15.35 billion2.25 million2.40 million
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
$298.16
+1.7%
11.90$13.45 billion324,403443,297Positive News
Insider Trade
Moderna, Inc. stock logo
MRNA
Moderna
$32.06
+1.5%
N/A$12.40 billion5.95 million8.88 millionAnalyst Forecast
Analyst Revision
Suzano S.A. Sponsored ADR stock logo
SUZ
Suzano
$9.11
+0.5%
N/A$12.06 billion1.21 million1.74 millionNews Coverage
Analyst Downgrade
Icon Plc stock logo
ICLR
Icon
$144.05
-1.1%
15.69$11.63 billion1.13 million1.12 millionNews Coverage
Upcoming Earnings
Revvity Inc. stock logo
RVTY
Revvity
$94.93
-1.0%
40.40$11.19 billion1.32 million975,725
Fabrinet stock logo
FN
Fabrinet
$297.55
-1.3%
33.13$10.66 billion482,799649,936Positive News
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$314.83
+0.7%
24.03$9.05 billion324,337378,267Upcoming Earnings
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
$154.97
+0.4%
N/A$7.61 billion526,5561.03 millionNews Coverage
Positive News
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
$39.75
+0.4%
N/A$7.30 billion1.99 million1.37 millionGap Up
Bio-Rad Laboratories, Inc. stock logo
BIO.B
Bio-Rad Laboratories
$257.75
N/A$7.01 billion1528
Lumentum Holdings Inc. stock logo
LITE
Lumentum
$99.63
+1.5%
N/A$6.91 billion2.01 million2.53 million
TG Therapeutics, Inc. stock logo
TGTX
TG Therapeutics
$38.84
+2.3%
161.83$6.17 billion1.86 million2.87 millionPositive News
Bloom Energy Corporation stock logo
BE
Bloom Energy
$24.71
-2.4%
N/A$5.74 billion6.34 million6.49 millionAnalyst Forecast
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
$131.19
+1.7%
N/A$5.48 billion1.05 million1.47 millionPositive News
Vaxcyte, Inc. stock logo
PCVX
Vaxcyte
$36.57
+3.7%
N/A$4.72 billion1.18 million1.87 millionNews Coverage
Positive News
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
$150.08
+1.6%
36.08$4.34 billion280,450287,524Analyst Revision
ODDITY Tech Ltd. stock logo
ODD
ODDITY Tech
$74.01
+1.3%
42.53$4.13 billion1.63 million618,715News Coverage
Analyst Forecast
High Trading Volume
Hercules Capital, Inc. stock logo
HTGC
Hercules Capital
$19.20
+0.9%
14.43$3.37 billion932,3471.12 millionAnalyst Forecast
Ascentage Pharma Group International - Unsponsored ADR stock logo
AAPG
Ascentage Pharma Group International
$38.62
+5.1%
N/A$3.36 billion12,40447,742News Coverage
Redwire Corporation stock logo
RDW
Redwire
$17.55
+3.3%
N/A$2.50 billion4.26 million1.54 millionAnalyst Forecast
Gap Up
High Trading Volume
ImmunityBio, Inc. stock logo
IBRX
ImmunityBio
$2.76
+0.7%
N/A$2.44 billion6.40 million6.30 million
Twist Bioscience Corporation stock logo
TWST
Twist Bioscience
$36.69
+0.9%
N/A$2.20 billion714,4851.09 million
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
$5.39
+3.3%
N/A$2.19 billion24.15 million16.75 million
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
$14.87
+4.9%
N/A$2.16 billion2.45 million1.15 millionPositive News
High Trading Volume
Bank of America Says Gold Could Hit $4,000. Here How to Get Paid (Ad)

“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist believed — until he found a little-known $15 gold ETF that’s now paying up to 64% annually in monthly cash. No mining stocks. No futures. Just steady income from an asset that used to pay nothing.

See the gold income fund paying 64% annually
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
$20.07
+2.5%
N/A$2.02 billion2.08 million2.03 million
JPMorgan U.S. Tech Leaders ETF stock logo
JTEK
JPMorgan U.S. Tech Leaders ETF
$84.72
+0.6%
47.07$2.01 billion151,068243,996Positive News
Amicus Therapeutics, Inc. stock logo
FOLD
Amicus Therapeutics
$6.07
+2.7%
N/A$1.87 billion3.24 million3.79 million
Standex International Corporation stock logo
SXI
Standex International
$154.01
-2.5%
30.44$1.86 billion173,57866,474News Coverage
Positive News
High Trading Volume
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
$8.59
-1.5%
N/A$1.80 billion2.94 million3.04 millionAnalyst Revision
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
$35.75
+1.7%
N/A$1.80 billion157,445342,786
Apogee Therapeutics Inc. stock logo
APGE
Apogee Therapeutics
$38.37
+3.3%
N/A$1.77 billion854,476609,478
Adaptive Biotechnologies Corporation stock logo
ADPT
Adaptive Biotechnologies
$10.83
-2.1%
N/A$1.65 billion2.14 million1.64 million
Phreesia, Inc. stock logo
PHR
Phreesia
$27.04
+1.1%
N/A$1.61 billion297,316453,862Analyst Forecast
10x Genomics stock logo
TXG
10x Genomics
$12.37
+1.2%
N/A$1.52 billion2.79 million3.45 million
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
$23.56
+1.6%
N/A$1.50 billion953,1951.31 millionPositive News
Evotec AG stock logo
EVO
Evotec
$4.22
+0.5%
N/A$1.50 billion34,998135,624
Azenta, Inc. stock logo
AZTA
Azenta
$32.08
+0.5%
N/A$1.47 billion598,260738,083
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
$16.79
+3.3%
N/A$1.37 billion585,3141.15 million
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
$11.86
+3.1%
N/A$1.35 billion2.38 million1.60 millionInsider Trade
Analyst Revision
Oaktree Specialty Lending Corp. stock logo
OCSL
Oaktree Specialty Lending
$14.61
+1.1%
112.38$1.29 billion462,933764,644Positive News
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
$7.82
+1.4%
N/A$1.22 billion5.08 million1.32 millionNews Coverage
Analyst Forecast
Gap Up
High Trading Volume
Novavax, Inc. stock logo
NVAX
Novavax
$6.96
+1.2%
2.63$1.13 billion3.09 million6.22 millionPositive News
ProKidney Corp. stock logo
PROK
ProKidney
$3.73
+10.7%
N/A$1.09 billion11.38 million6.17 millionTrending News
Analyst Forecast
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
$9.33
+12.7%
N/A$1.06 billion5.45 million1.91 millionNews Coverage
Analyst Forecast
Insider Trade
Gap Up
High Trading Volume
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
$52.26
+1.5%
N/A$1.05 billion436,317205,197Positive News
High Trading Volume
Tutor Perini Corporation stock logo
TPC
Tutor Perini
$19.12
-60.8%
N/A$1.01 billion850,297569,255
Spyre Therapeutics, Inc. stock logo
SYRE
Spyre Therapeutics
$16.20
+5.8%
N/A$976.47 million378,259578,113News Coverage
Positive News
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
$4.33
+3.6%
N/A$976.33 million3.52 million5.95 million
Replimune Group, Inc. stock logo
REPL
Replimune Group
$12.63
+1.9%
N/A$973.61 million4.10 million1.09 millionNews Coverage
Analyst Forecast
Options Volume
Gap Up
High Trading Volume
Zymeworks Inc. stock logo
ZYME
Zymeworks
$13.52
+5.0%
N/A$942.11 million537,710578,080
Thermon Group Holdings, Inc. stock logo
THR
Thermon Group
$27.68
+0.3%
17.63$920.08 million135,253171,115Positive News
Diversified Healthcare Trust stock logo
DHC
Diversified Healthcare Trust
$3.71
-1.9%
N/A$895.04 million941,237987,928Positive News
Dividend Announcement
MENS
Jyong Biotech
$11.72
+0.2%
N/A$891.05 million44,691303,689Positive News
abrdn Healthcare Investors stock logo
HQH
abrdn Healthcare Investors
$15.72
+0.8%
N/A$846.93 million168,295199,751News Coverage
Positive News
Immunome, Inc. stock logo
IMNM
Immunome
$9.65
+14.9%
N/A$839.65 million1.77 million906,396News Coverage
Positive News
Gap Up
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
$26.86
+0.9%
N/A$789.15 million476,326649,039
Transcat, Inc. stock logo
TRNS
Transcat
$83.29
+0.9%
53.39$776.26 million61,44192,315
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
$8.43
+3.8%
N/A$751.45 million2.04 million1.16 million
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
$2.24
+15.5%
N/A$748.01 million24.57 million9.35 millionAnalyst Downgrade
High Trading Volume
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
$5.41
+2.1%
N/A$747.88 million1.26 million1.37 million
Tango Therapeutics, Inc. stock logo
TNGX
Tango Therapeutics
$6.35
+7.4%
N/A$688.28 million2.43 million1.62 millionPositive News
Blackrock Tcp Capital Corp. stock logo
TCPC
Blackrock Tcp Capital
$7.80
+0.4%
N/A$663.31 million325,905595,700Analyst Downgrade
Urogen Pharma stock logo
URGN
Urogen Pharma
$14.34
+2.1%
N/A$661.17 million775,7551.61 million
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
$19.84
+4.2%
N/A$638.05 million326,105316,622
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
$9.88
+11.6%
N/A$627.08 million2.31 million187,470News Coverage
Positive News
Gap Up
High Trading Volume
Upstream Bio, Inc. stock logo
UPB
Upstream Bio
$10.92
-2.0%
N/A$587.39 million389,732350,794
Tyra Biosciences, Inc. stock logo
TYRA
Tyra Biosciences
$10.92
+7.8%
N/A$579.74 million222,901290,847
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
$9.58
+1.6%
N/A$560.66 million1.28 million1.43 millionGap Up
Rapport Therapeutics, Inc. stock logo
RAPP
Rapport Therapeutics
$15.22
+5.8%
N/A$555.53 million141,978165,839News Coverage
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
$14.80
+3.9%
N/A$554.13 million100,129233,885News Coverage
Positive News
Arvinas, Inc. stock logo
ARVN
Arvinas
$7.59
+2.6%
N/A$554.00 million1.67 million1.49 millionNews Coverage
Prime Medicine, Inc. stock logo
PRME
Prime Medicine
$4.04
-5.8%
N/A$543.36 million7.38 million1.75 millionNews Coverage
High Trading Volume
Septerna, Inc. stock logo
SEPN
Septerna
$11.99
+2.7%
N/A$534.27 million222,764766,508
Celcuity, Inc. stock logo
CELC
Celcuity
$13.86
+0.6%
N/A$524.82 million198,632273,852
This Cold War “Accident” Could Unleash New $100 Trillion AI Boom (Ad)

Obscure Metal More Valuable than Gold and Bitcoin… COMBINED? This strange "AI Metal" holds the key to the $100 trillion AI boom. Which is why Jeff Brown recently traveled to a location that has one of the highest concentrations of this metal in the world. And you won't believe what he uncovered.

Click here to see the details because this could be the biggest tech story of this decade.
Tourmaline Bio, Inc. stock logo
TRML
Tourmaline Bio
$18.54
-0.1%
N/A$476.11 million108,841254,652News Coverage
Positive News
Standard BioTools Inc. stock logo
LAB
Standard BioTools
$1.24
+1.6%
N/A$470.98 million2.01 million1.94 millionPositive News
PureTech Health PLC Sponsored ADR stock logo
PRTC
PureTech Health
$18.59
+3.5%
N/A$446.41 million1,5214,903News Coverage
Gap Up
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
$4.90
+3.8%
N/A$443.45 million1.69 million1.96 millionTrending News
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
$8.50
+3.2%
N/A$426.36 million537,496923,518
Runway Growth Finance Corp. stock logo
RWAY
Runway Growth Finance
$11.10
+0.2%
6.69$414.59 million319,739321,337News Coverage
Positive News
Analyst Forecast
Wabash National Corporation stock logo
WNC
Wabash National
$9.86
-1.2%
N/A$412.80 million1.60 million789,834News Coverage
Upcoming Earnings
Gap Down
High Trading Volume
Vigil Neuroscience, Inc. stock logo
VIGL
Vigil Neuroscience
$8.07
+0.1%
N/A$384.86 million325,336684,755
abrdn Life Sciences Investors stock logo
HQL
abrdn Life Sciences Investors
$13.08
+0.9%
N/A$377.53 million107,406107,650News Coverage
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
$6.95
+5.9%
N/A$349.38 million193,353209,416Positive News

Biotech Stocks Frequently Asked Questions

Biotech stocks represent shares of companies in the biotechnology sector, which focuses on using biological processes, organisms, or systems to develop products that improve health, fight diseases, and benefit the environment. This sector includes companies that work on drug development, genetic research, biologically derived materials, and more. Due to the innovative and often breakthrough nature of their work, biotech stocks are known for their volatility but also for their potential to offer substantial returns.

Prominent players in the biotech sector include large, well-established companies such as Amgen, Gilead Sciences, and Biogen, which have multiple products on the market and solid research pipelines. Younger companies like Moderna and Regeneron are also notable, especially for their roles in developing treatments and vaccines at an accelerated pace in response to global health crises. These companies represent a mix of stable investments and high-growth potentials within the biotech industry.

While biotech exists in other areas, the majority of the biotech stocks are in the medical and agricultural sectors. Investors might choose individual stocks of companies they believe have potential based on their pipelines or existing products. However, due to the high risk associated with the biotech sector, many opt to diversify their exposure through biotech ETFs or mutual funds, which include a range of companies from startups to established leaders. This strategy can mitigate some of the risks while allowing investors to benefit from the sector's overall growth.

Before investing in biotech stocks, consider the unique risks of this sector, including high development costs, regulatory hurdles, and the binary nature of clinical trial results, which can dramatically affect a company's stock price. Investors should be prepared for volatility and have a tolerance for risk. It is also crucial to research and understand the specific focus areas of biotech companies, as these can vary widely from medical devices and pharmaceuticals to agricultural and environmental biotechnologies. Consulting with a financial advisor who understands the biotech sector can provide valuable insights and guidance tailored to your financial goals.